On behalf of @AccessibleMeds’ Biosimilars Council, Cory Wohlbach, global vice president at @TevaUSA, noted: “When y… https://t.co/aA2bQBGIAT
On behalf of @AccessibleMeds’ Biosimilars Council, Cory Wohlbach, global vice president at @TevaUSA, noted: “When y… https://t.co/aA2bQBGIAT